Posted by mrsleepypants on August 22, 2008 at 09:38:46:

In Reply to: Synthetic Hypocretin / Orexin posted by Yawn on August 12, 2008 at 01:32:58:

Also found this:

SB649868 is under development by GlaxoSmithKline for sleep disorders; it is an orexin receptor antagonist. ACT-078573 is a similar compound under development by Actelion.

SB649868 is an orexin receptor antagonist in development by GlaxoSmithKline. Currently in Phase 2 development, this drug for sleep disorders is one of two such compounds currently in development, the other being Actelion's ACT-078573.

Follow Ups:

---

Post a Followup

E-Mail  :  required - same address used when you registered (will not show up in posting)
Password:  required (sent to you when you registered)

Subject : Re: Synthetic Hypocretin / Orexin

Comments:....note: including your email address here will result in the removal of your posting (See removal policy)

 

PLEASE ONLY CLICK THE SUBMIT FOLLOW UP BUTTON ONCE!!. Thanks, Sandman

---

[ Follow Ups ] [ Post Followup ] [ Narcolepsy Forum28 ] [ FAQ ]

WWWBoard 2.0a and WWWAdmin 2.0a © 1997, All Rights Reserved.
Matt Wright